vanthana bharathi

@mdandersonnews Leukemia Fellow

[Andrew Kuykendall MD @KuykendallMd]

https://t.co/lZugQbzHBt

Big day for patients with polycythemia vera! #MPNSM @MoffittNews @MoffittResearch @doctorpemm @TakedaOncology @ProtagonistTx

[NASA @NASA]

Sky full of stars.

Following a successful lunar flyby, the Artemis II astronauts captured this breathtaking photo of our galaxy, the Milky Way, on April 7, 2026.

[NEJM @NEJM]

In a phase 1 study of the oral p53 reactivator rezatapopt in heavily pretreated patients with TP53 Y220C–mutated solid tumors, the most common adverse events were nausea and vomiting, and the overall response was 20%. Full PYNNACLE study results: https://t.co/LBqROGlouc

Science behind the Study: Restoring Function to a Variant of p53 in Solid Tumors https://t.co/5Ox6Kuax6Q

[Nitin Jain @NitinJainMD]

👉👉👉Super delighted to share our recent paper on combined ibrutinib + venetoclax in R/R CLL.
Blood Cancer Discovery @BCD_AACR
- 79 pts. Median 1 prior Rx
- No prior BTKi or BCL2i use
- Median follow-up 95 months
- 7 yr PFS 63%
@MDAndersonNews

https://t.co/HUK1bUrHtH

[Vivek Subbiah, MD @VivekSubbiah]

NCCN Guidelines to Be Integrated Into OpenEvidence's Medical AI Platform https://t.co/6FgGZXtJNQ

[Somedeb Ball @drsomedeb]

P2 Elritercept data showing encouraging HI/ response in certain difficult to treat subsets of high transfusion burden and non-RS LR-MDS. ANC and platelet improvements are modest. Look forward to global P3 #RENEW study. #MDSsm #ASH25 @AshKishtagari @Ramikomrokji

[Vincent Rajkumar @VincentRK]

FDA Approves First Cellular Therapy to Treat Patients with Severe Aplastic Anemia | FDA #ASH25 https://t.co/qSuvlBzklF

[UT MD Anderson @UTMDAnderson]

The menin-MLL inhibitor enzomenib (DSP-5336) is well tolerated, our Dr. Naval Daver presented at #ASH25. Further dose optimization in patients with relapsed or refractory NPM1m acute myloid leukemia is ongoing. @Daver_Leukemia #EndCancer

[calliecoombs @calliecoombsmd]

Wow this is beautiful work @KellyLBolton looking at CDK4/6 inhibitors as CHIP-protection in solid tumor pts getting chemo! #ASH25

[vanthana bharathi @drvanthanab]

@doctorpemm @MDAndersonNews Thank you @doctorpemm!

[UT MD Anderson @UTMDAnderson]

In a six-year prospective study with more than 1,000 patients with chronic lymphocytic leukemia (CLL), the reminder (in the form of the survey itself) seemed to lead to greater screenings for other types of cancer, including prostate and skin cancer. Our Dr. Vanthana Bharathi presented the results at #ASH25 this morning. @drvanthanab #EndCancer

[Dr. Len Zon @leonard_zon]

We have the cover of Cell today. Craters on the surface of melanoma serve as an immune hub for CD8+ T cells. A timely highlight as we roll into Thanksgiving.

[Naveen Pemmaraju, MD @doctorpemm]

👉👉👉Happy to share our group’s new report in #MPNSM field led by Dr .@drvanthanab & Dr @NitinJainMD

#FIP1L1 - #PDGFRA @drsangeetmd

https://t.co/w9OZ249iby

[Nitin Jain @NitinJainMD]

👉👉 Case report of a patient with FIP1L1-PDGFRA fusion with significant extra medullary involvement with cord compression
👉10+ year remission with single agent imatinib without any chemotherapy indicating exquisite sensitivity of this fusion to imatinib
https://t.co/V6Iy3bOAYP

[Bloodman @Bloodman]

ASH Plenary - IV Iron safe in infections! https://t.co/95lVMroo34

[vanthana bharathi @drvanthanab]

I received an Abstract Achievement Award from @ash_hematology! Grateful for this recognition and excited to present my research to the #hematology community at #ASH25!

[vanthana bharathi @drvanthanab]

FDA approves revumenib for relapsed or refractory acute myeloid leukemia with a susceptible NPM1 mutation | FDA #leusm #amlsm https://t.co/SQiFHJQHte

[vanthana bharathi @drvanthanab]

@Torsadepointles @ECFMG_IMG @Inside_TheMatch @LtmmcM @UTHealthHouston @HamsaMurli @Behera_Ritika98 @SaloniHaldule All the best!

[iwCLL @iwCLL]

🚨 Just 1 week to go! 🚨

#iwCLL2025 is almost here!

❇️Explore the latest breakthroughs in #CLL research
❇️Discuss practical strategies for patient care
❇️Connect with global experts in the field

Register now: https://t.co/Ds1v2ntsjE

[vanthana bharathi @drvanthanab]

So proud of @andrescaldv 👏🏻 Giant Ectopic Parathyroid Adenoma Mimicking Parathyroid Carcinoma https://t.co/fWnKAFVbQF